pharmaphorum
AUGUST 31, 2021
Shares in AC Immune leaped today after the company said its tau-targeting Alzheimer’s disease candidate semorinemab hit one of its objectives in a phase 2 trial, although it missed another. Roche’s Genentech unit bought into the programme in 2012 and amended it three years later.
pharmaphorum
JANUARY 27, 2022
Lab studies have suggested that this type of stimulation can alter immune cells made in the spleen switching them from a pro-inflammation to an anti-inflammation state. Galvani is using its device to stimulate the splenic nerve, which sends signals to the spleen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
APRIL 28, 2021
“Text mining was also able to highlight new insights into the mechanisms of pancreatic cancer’s immune evasion, which refers to cancer cells’ ability to evade an immune response” . This was only discovered in 2012 and is a currently active area of research within pancreatic cancer.
FDA Law Blog: Biosimilars
APRIL 30, 2023
Senate Committee on Health, Education, Labor and Pensions (“Senate HELP”) is scheduled to take up legislation that could significantly limit access to the courts and immunize critical FDA decisions from timely judicial review. 112-144 (2012). Importantly, because FDA has sovereign immunity from damages claims, sponsors trapped in S.
pharmaphorum
SEPTEMBER 13, 2022
Crucially, he observed a connection between certain tumours and inflammation, noting that neoplastic tissues were often covered with leukocytes of the immune system. Building on the success of cytokine-based immunotherapies, scientists continued to seek other areas where the immune system could be leveraged against tumours.
The Thyroid Pharmacist
AUGUST 12, 2022
This means that our immune system recognizes the thyroid gland as a foreign invader and begins to attack it, eventually leading to the destruction of our thyroid tissue. Left unbalanced, the immune system may go on to attack different parts of the body, leading to the development of other autoimmune conditions.
Express Pharma
AUGUST 16, 2023
The most important advantage of iPSCs is their potential to produce patient-specific cells which can be transplanted to the site of injury or the site of tissue degeneration due to various disease conditions, and thereby, eliminate any chance of immune rejection.
Expert insights. Personalized for you.
52 
Let's personalize your content